Skip to main content
. 2025 Jan 15;272(2):135. doi: 10.1007/s00415-024-12868-2

Table 4.

Immunosuppressive treatment

Treatment Group 1 Group 2 p value
n % n %
Glucocorticoid 27 100 64 96 0.264
Infliximab 6 22 16 24 0.864
Rituximab 1 4 1 1 0.502
Azathioprine 1 4 17 25 0.016
Cyclophosphamide 6 22 1 1  < 0.001
Methotrexate 9 33 22 33 0.963
Others 5 19 4 6 0.061

N = all patients with record of treatment (27 patients in group; 67 patients in group 2), values in bold are statistically significant